Rheumatoid Arthritis

Latest News

Making “Rheum” for Biosimilars: Overcoming Reluctance
Making “Rheum” for Biosimilars: Overcoming Reluctance

February 19th 2024

Despite the proven efficacy of biosimilars, both patients and health care providers often have some reluctance when switching from an originator drug to a biosimilar.

Close up of rheumatism / arthritis medical examination. | Image Credit: narstudio - stock.adobe.com
Biosimilar Adalimumab, Etanercept Have Equivalent Effectiveness to Reference Drugs Over 48 Months

February 9th 2024

Young woman having rheumatoid arthritis takes a rest sitting on the couch elected focus. | Image Credit: Valentina - stock.adobe.com
Celltrion Seeks Approval From FDA for CT-P47 as Biosimilar of Tocilizumab

February 6th 2024

BIOSIMILARS - pharmaceutical concept | Image Credit: hafakot - stock.adobe.com
Study: Biosimilarities Found Between Yusimry and Humira for Immune, Rheumatic Conditions

January 5th 2024

Medical and Informatics Icons on Technology Background | Image Credit: ArtemisDiana - stock.adobe.com
FDA Accepts Supplemental Biologics License Application for Hadlima for Interchangeability With Humira

November 10th 2023

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.